Press release: STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio
One document
more
Stories about Medizin, Gesundheit
- 5
Reflecting on a successful Pharma Forum 2023
One documentmore - 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
One documentmore canSERV Releases Open Call for Transnational Service Provision
One documentmore- 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
One documentmore Terre des Hommes Deutschland e.V.
UN Committee on the Rights of the Child calls on states to take action in first guidance on children's rights and the environment, with a focus on climate change
GENEVA/NEW YORK (ots) - Today, the United Nations Committee on the Rights of the Child published authoritative guidance to States on what they must do to uphold children’s right to a clean, healthy and sustainable environment. In the face of the ...
One documentmore- 2
Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty
One documentmore - 4
Sysmex Europe SE launches XR-Series, the new flagship product line for laboratory haematology
One documentmore Press release : STADA further grows its European Consumer Healthcare portfolio by acquiring several additional brands from Sanofi
One documentmore- 2
Press Release: Aurubis subsidiary RETORTE expanding selenium production for profitable growth markets
One documentmore Press release: STADA appoints Christos Gallis as Head of Eastern Europe
One documentmoreJoint Statement: health organisations define EHDS’ opt-out required for life-saving research
One documentmore- 2
PM: „Get Airports Ready for Disaster“-Programm in Sarajevo / PR: Get Airports Ready for Disaster Program held in Sarajevo
2 Documentsmore Gerresheimer with a good start to 2023 financial year: Again double-digit growth in revenues and Adjusted EBITDA
Düsseldorf (ots) - - First-quarter revenues grew organically by 21.0% - Adjusted EBITDA up organically by 24.8% - Gerresheimer confirms guidance for financial year 2023 Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug ...
One documentmorePress release: STADA and Xbrane launch ranibizumab to support patient access in Europe
STADA and Xbrane launch ranibizumab to support patient access in Europe - Ranibizumab biosimilar is being launched in major European markets - Ranibizumab is the first product brought to market through a strategic collaboration between STADA and Xbrane, marking Xbrane’s first commercial launch and ...
One documentmore- 5
Press Release - hubergroup India expands its support for rural healthcare
One documentmore Press release: STADA sustains strong momentum with double-digit sales and profit growth in 2022
One documentmoreFree Access to Cancer Research Services - canSERV 1st Call for Proposals
One documentmoreInnovation and Start-up Center Biotechnology (IZB) welcomes Invitris
One documentmoreTime makes the difference, PI 16/2023
Time makes the difference About 18,000 physicians from Cuba came to Brazil between 2013 and 2018 during the "More Doctors for Brazil" project. The programme aimed at alleviating the public health emergency, however, initially met with surprising resistance, as Konstanz anthropologist Maria Lidola observed in Rio de Janeiro. When countries in the Global ...
One documentmorePress release: EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) - Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) ...
One documentmorePress release: Adalvo and STADA extend their strategic partnership
Adalvo and STADA extend their strategic partnership - Strategic partnership in Europe extended to cover five additional molecules in therapeutic categories including oncology and diabetes - Adalvo CEO Anil Okay: “These new agreements demonstrate the significance of the strategic partnership we have built with STADA, in the last couple of years. We take ...
One documentmorePress release: STADA appoints Boris Döbler as Chief Financial Officer
One documentmorePress release: Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe
Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe - Launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe - Follows initial introduction of adalimumab in ninecountries: ...
One documentmoreGerresheimer to expand significantly in High Value Solutions and further accelerates its sustainable profitable growth
Düsseldorf (ots) - At today’s Capital Markets Day, Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted ...
One documentmore- 3
Press release: STADA starts work on >EUR50m facility to strengthen European medicines supply
One documentmore Press release: Stéphane Jacqmin joins STADA from Sanofi and becomes Head of Emerging Markets
One documentmore- 5
Press Release - hubergroup India supports rural areas with medical vans
One documentmore - 6
Press release: Aurubis plants in Hamburg and Lünen receive internationally recognized Copper Mark quality seal
One documentmore - 3
Press release: Maintenance shutdown at Aurubis plant in Hamburg completed successfully
One documentmore
Previous1234Next